| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/EURHEARTJ/EHM581 |
| P698 | PubMed publication ID | 18187561 |
| P50 | author | Lidia Brydak | Q11756548 |
| Witold Rużyłło | Q9375823 | ||
| Zofia Bilińska | Q48861383 | ||
| Andrzej Ciszewski | Q110727099 | ||
| Cezary Kępka | Q110727102 | ||
| Mariusz Kruk | Q110727115 | ||
| Ewa Księżycka-Majczyńska | Q114453099 | ||
| Renata Maczynska | Q114453113 | ||
| P2093 | author name string | Walerian Piotrowski | |
| Jakub Przyluski | |||
| Magdalena Romanowska | |||
| P433 | issue | 11 | |
| P921 | main subject | coronary artery disease | Q844935 |
| P304 | page(s) | 1350-1358 | |
| P577 | publication date | 2008-01-10 | |
| P1433 | published in | European Heart Journal | Q2286839 |
| P1476 | title | Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study | |
| P478 | volume | 29 |
| Q39007236 | 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines |
| Q94572312 | A Call for Vaccine Against COVID-19: Implications for Cardiovascular Morbidity and Healthcare Utilization |
| Q37206975 | A Matched Influenza Vaccine Strain Was Effective in Reducing the Risk of Acute Myocardial Infarction in Elderly Persons: A Population-Based Study |
| Q33647497 | ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathy |
| Q30363101 | Activation of coagulation and tissue fibrin deposition in experimental influenza in ferrets |
| Q35793997 | Acute cardiac injury events ≤30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010-2012. |
| Q38574447 | Acute myocardial infarction and influenza: a meta-analysis of case-control studies |
| Q30425495 | Acute myocardial infarctions, strokes and influenza: seasonal and pandemic effects |
| Q51887243 | Anti-influenza vaccination in systemic lupus erythematosus patients: an analysis of specific humoral response and vaccination safety. |
| Q84696093 | Antibody response to influenza immunization in coronary artery disease patients: a controlled trial |
| Q31159585 | Can Vaccinations Improve Heart Failure Outcomes?: Contemporary Data and Future Directions |
| Q40364939 | Cardiac Rehabilitation: Underrecognized/Underutilized |
| Q47685898 | Cardioprotective effect of influenza and pneumococcal vaccination in patients with cardiovascular diseases |
| Q96304380 | Causal relationship between influenza infection and risk of acute myocardial infarction: pathophysiological hypothesis and clinical implications |
| Q39253162 | Cost effectiveness of influenza vaccination in patients with acute coronary syndrome in Korea |
| Q93034336 | Cost-benefit analysis of a national influenza vaccination program in preventing hospitalisation costs in Australian adults aged 50-64 years old |
| Q64082627 | Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US |
| Q83445201 | Effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects in Madrid (Spain) |
| Q34290844 | Effectiveness of the influenza vaccine at preventing hospitalization due to acute exacerbation of cardiopulmonary disease in Korea from 2011 to 2012. |
| Q30353405 | Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis. |
| Q30384321 | Factors contributing to suboptimal vaccination against influenza: results of a nationwide telephone survey of persons with cardiovascular disease. |
| Q36176158 | Family doctor responses to changes in incentives for influenza immunization under the U.K. Quality and Outcomes Framework pay-for-performance scheme |
| Q57243422 | Guías de Práctica Clínica de la Sociedad Europea de Cardiología (ESC). Manejo del infarto agudo de miocardio en pacientes con elevación persistente del segmento ST |
| Q35915081 | Infection and Atherosclerosis Development |
| Q90486818 | Influenza Infections and Emergent Viral Infections in Intensive Care Unit |
| Q37711138 | Influenza Vaccination for Secondary Prevention of Cardiovascular Events: A Systematic Review. |
| Q37602840 | Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review |
| Q38082593 | Influenza diagnosis and vaccination in Poland. |
| Q36368673 | Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study |
| Q96343635 | Influenza vaccination as a novel means of preventing coronary heart disease: Effectiveness in older adults |
| Q52565679 | Influenza vaccination in the elderly: Is a trial on mortality ethically acceptable? |
| Q43170356 | Influenza vaccine and survival in acute heart failure |
| Q28076254 | Influenza vaccine as a coronary intervention for prevention of myocardial infarction |
| Q42204827 | Influenza vaccine as prevention for cardiovascular diseases: possible molecular mechanism |
| Q24188037 | Influenza vaccines for preventing cardiovascular disease |
| Q34951441 | Interferon-gamma increases the ratio of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in peripheral monocytes from patients with coronary artery disease |
| Q34365689 | Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study. |
| Q22242896 | Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology: |
| Q30239853 | Management standards for stable coronary artery disease in India |
| Q26773268 | Medical management of chronic stable angina |
| Q41162869 | Nasal priming with immunobiotic Lactobacillus rhamnosus modulates inflammation-coagulation interactions and reduces influenza virus-associated pulmonary damage |
| Q103002020 | Protective effect of influenza vaccination on cardiovascular diseases: a systematic review and meta-analysis |
| Q37683958 | Role of acute infection in triggering acute coronary syndromes. |
| Q33826541 | Safety and tolerability of intradermal influenza vaccination in patients with cardiovascular disease |
| Q39458911 | The Hidden Burden of Influenza: A Review of the Extra-Pulmonary Complications of Influenza Infection |
| Q36864182 | The Modification Effect of Influenza Vaccine on Prognostic Indicators for Cardiovascular Events after Acute Coronary Syndrome: Observations from an Influenza Vaccination Trial |
| Q58114136 | The effect of influenza vaccination on mortality and hospitalization in patients with heart failure: a systematic review and meta-analysis |
| Q82964283 | The effect of influenza vaccination on risk of acute myocardial infarction: self-controlled case-series study |
| Q89496671 | Type 2 Myocardial Infarction: A Geriatric Population-based Model of Pathogenesis |
| Q30416654 | What Every Cardiologist Should Know about H1N1? |
| Q81584332 | Why young healthy adults should become a target group for the influenza vaccination: a cardiologist's point of view |
Search more.